Prospective Cohort Study of Health Complaints

NCT ID: NCT01682278

Last Updated: 2022-03-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

118 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-09-30

Study Completion Date

2021-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to evaluate if amalgam removal is associated with improved self-reported health, compared to no amalgam removal. The main target group consists of a group of patients with medically unexplained physical symptoms (MUPS), which they attribute to dental amalgam restorations. The patients should furthermore express the wish to have these amalgam fillings removed. The project is designed as a prospective cohort study, consisting of three groups recruited separately. The main target group will be compared with two comparison groups: one group of patients with MUPS recruited from general practice and one group of healthy study patients, recruited at dental practice. The primary research question is if amalgam removal is associated with improved self-reported health, compared to no amalgam removal, one year after completed amalgam removal.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In Norway 5%-8% of the adult population believe that their amalgam fillings have affected their health adversely; and a similar proportion of the adult population has had their amalgam fillings removed for health reasons only. The Norwegian Ministry of Health and Care Services has decided to fund a project comprising experimental treatment (i.e. removal of amalgam fillings) for patients with health complaints which they attribute to dental amalgam. The aim of this study is to evaluate the intervention by measuring health complaints and quality of life before and after amalgam removal and to compare changes over time with relevant patient groups. Amalgam-attributed health complaints are heterogeneous and a variety of symptoms have been attributed to amalgam. Therefore, amalgam related health complaints are difficult to quantify. However, amalgam-attributed health complaints are largely similar to complaints experienced by patients with so called "medically unexplained physical symptoms" (MUPS). Therefore, in order to operationalize and measure the patient's subjective health complaints, the MUPS criteria and questionnaire will be applied to patients who attribute their health problems to amalgam. Furthermore, this strategy allows for the inclusion of patients suffering from MUPS, however without any attribution to amalgam. This group of patients can serve as a comparison group with a similar symptom load, but no subjective attribution to amalgam. For the interpretation of the study outcome, the natural course of the health complaints in this group is of high importance.

Therefore, the project is designed as a prospective cohort study, consisting of three groups recruited separately. The two comparison groups consist of one group of patients with MUPS recruited from general practice and one group of healthy study patients, recruited at dental practice. These study participants are recruited regardless of amalgam status. The main target group consists of a group of patients with medically unexplained physical symptoms, which they attribute to dental amalgam restorations. The patients should furthermore express the wish to have these amalgam fillings removed ("amalgam cohort"). Patients with amalgam attributed health complaints who suffer from medically explained disease but attribute their diagnosis and course of the disease to amalgam (thus, not included in the amalgam cohort), will be included in a separate case series ("amalgam - case series", to be registered as a separate study).

Patients in the "amalgam cohort" will have all amalgam fillings removed according to pre-defined criteria. Amalgam removal will be performed by the patient's regular dentist or another dentist chosen by the patient. After completed removal, patients in the amalgam groups will be examined at a Regional Dental Center of Competence. The costs of amalgam removal will be reimbursed according to pre-defined rules.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Health Complaints Attributed to Dental Amalgam Restorations

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Amalgam cohort

Patients with medically unexplained physical symptoms attributed to dental amalgam restorations which the patient wish to have removed.

Removal of dental amalgam restorations

Intervention Type DEVICE

Patients in the "amalgam cohort" will have all dental amalgam restorations removed and replaced with other restorative materials used in modern dentistry. Amalgam removal will be performed by the patient's regular dentist or another dentist chosen by the patient.

MUPS-cohort

Patients with medically unexplained physical symptoms without attribution to amalgam and no explicit wish to remove amalgam.

No interventions assigned to this group

Dental cohort

Healthy comparison group: Subjectively healthy without diagnosed chronic disease or prescribed medication.

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Removal of dental amalgam restorations

Patients in the "amalgam cohort" will have all dental amalgam restorations removed and replaced with other restorative materials used in modern dentistry. Amalgam removal will be performed by the patient's regular dentist or another dentist chosen by the patient.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* permanent residents in Norway
* able to comply with the protocol

Amalgam Cohort:

* Health complaints attributed (by the patient) to dental amalgam restorations
* duration of the health complaints attributed to amalgam restorations (by the patient) at least 3 months
* presence of at least one amalgam filling
* the patient has expressed a wish to have all amalgam fillings removed
* patient examined by patient's physician and dentist according to guidelines from the Norwegian Directorate of Health
* diagnosed diseases adequately treated
* patient's general practitioner/family physician and dentist assess that the patient's general health and dental health most likely will not deteriorate due to participation in the project
* patient's dentist assess that there are no major risks for dental complications following amalgam removal (e.g. need for root canal treatments or extractions)
* subjective symptoms without corresponding objective findings after medical examination(s), including symptoms not explained by patient's diagnoses,
* moderate or severe functional impairment (assessed by the physician)

MUPS-cohort:

* duration of unspecific health complaints at least 3 months
* subjective symptoms without corresponding objective findings after medical examination(s), including symptoms not explained by patient's diagnoses
* moderate or severe functional impairment (assessed by the physician)
* diagnosed diseases adequately treated
* no attribution to amalgam and no explicit wish to remove amalgam

Dental cohort:

* subjectively healthy without diagnosed chronic disease or prescribed medication

Exclusion Criteria

* pregnancy (or planned pregnancy) and lactation
* life threatening disease
* patients with ongoing cancers, severe cardiopulmonary, neurological, or psychiatric diseases (assessed by GP)
Minimum Eligible Age

20 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Bergen

OTHER

Sponsor Role collaborator

National Research Centre of Complementary and Alternative Medicine, Norway

OTHER

Sponsor Role collaborator

University of Witten/Herdecke

OTHER

Sponsor Role collaborator

NORCE Norwegian Research Centre AS

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lars Björkman, PhD

Role: PRINCIPAL_INVESTIGATOR

NORCE Norwegian Research Centre AS

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Uni Health

Bergen, , Norway

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Norway

References

Explore related publications, articles, or registry entries linked to this study.

Bjorkman L, Musial F, Alraek T, Werner EL, Weidenhammer W, Hamre HJ. Removal of dental amalgam restorations in patients with health complaints attributed to amalgam: A prospective cohort study. J Oral Rehabil. 2020 Nov;47(11):1422-1434. doi: 10.1111/joor.13080. Epub 2020 Aug 30.

Reference Type RESULT
PMID: 32810306 (View on PubMed)

Bjorkman L, Musial F, Alraek T, Werner EL, Hamre HJ. Mercury, silver and selenium in serum before and after removal of amalgam restorations: results from a prospective cohort study in Norway. Acta Odontol Scand. 2023 May;81(4):298-310. doi: 10.1080/00016357.2022.2143422. Epub 2022 Nov 16.

Reference Type DERIVED
PMID: 36383213 (View on PubMed)

Lamu AN, Bjorkman L, Hamre HJ, Alraek T, Musial F, Robberstad B. Validity and responsiveness of EQ-5D-5L and SF-6D in patients with health complaints attributed to their amalgam fillings: a prospective cohort study of patients undergoing amalgam removal. Health Qual Life Outcomes. 2021 Apr 17;19(1):125. doi: 10.1186/s12955-021-01762-4.

Reference Type DERIVED
PMID: 33865400 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

REK2012/331

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The Children's Amalgam Trial
NCT00065988 COMPLETED PHASE3